Ironwood Cash Conversion Cycle from 2010 to 2026
| IRWD Stock | USD 4.51 0.00 0.00% |
Cash Conversion Cycle | First Reported 2010-12-31 | Previous Quarter (15.97) | Current Value (16.77) | Quarterly Volatility 63.2 K |
Check Ironwood Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ironwood Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.7 M, Interest Expense of 20.1 M or Total Revenue of 227.9 M, as well as many indicators such as Price To Sales Ratio of 2.19, Dividend Yield of 0.0 or Days Sales Outstanding of 139. Ironwood financial statements analysis is a perfect complement when working with Ironwood Pharmaceuticals Valuation or Volatility modules.
Ironwood | Cash Conversion Cycle | Build AI portfolio with Ironwood Stock |
Analyzing Ironwood Pharmaceuticals's Cash Conversion Cycle over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Cash Conversion Cycle has evolved provides context for assessing Ironwood Pharmaceuticals's current valuation and future prospects.
Latest Ironwood Pharmaceuticals' Cash Conversion Cycle Growth Pattern
Below is the plot of the Cash Conversion Cycle of Ironwood Pharmaceuticals over the last few years. It is Ironwood Pharmaceuticals' Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ironwood Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Cash Conversion Cycle | 10 Years Trend |
|
Cash Conversion Cycle |
| Timeline |
Ironwood Cash Conversion Cycle Regression Statistics
| Arithmetic Mean | (15,795) | |
| Coefficient Of Variation | (400.38) | |
| Mean Deviation | 28,861 | |
| Median | (15.97) | |
| Standard Deviation | 63,238 | |
| Sample Variance | 4B | |
| Range | 262K | |
| R-Value | 0.16 | |
| Mean Square Error | 4.2B | |
| R-Squared | 0.03 | |
| Significance | 0.54 | |
| Slope | 1,992 | |
| Total Sum of Squares | 64B |
Ironwood Cash Conversion Cycle History
About Ironwood Pharmaceuticals Financial Statements
Ironwood Pharmaceuticals stakeholders use historical fundamental indicators, such as Ironwood Pharmaceuticals' Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Although Ironwood Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ironwood Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Ironwood Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ironwood Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash Conversion Cycle | (15.97) | (16.77) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ironwood Pharmaceuticals is a strong investment it is important to analyze Ironwood Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ironwood Pharmaceuticals' future performance. For an informed investment choice regarding Ironwood Stock, refer to the following important reports:Check out the analysis of Ironwood Pharmaceuticals Correlation against competitors. For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Will Biotechnology sector continue expanding? Could Ironwood diversify its offerings? Factors like these will boost the valuation of Ironwood Pharmaceuticals. Market participants price Ironwood higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ironwood Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 10.468 | Earnings Share 0.18 | Revenue Per Share | Quarterly Revenue Growth 0.333 | Return On Assets |
Investors evaluate Ironwood Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Ironwood Pharmaceuticals' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Ironwood Pharmaceuticals' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Ironwood Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ironwood Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Ironwood Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.